JUL 19, 2020 5:25 AM PDT

Common Biomarker Could Predict Heart Disease

WRITTEN BY: Carmen Leitch

Heart failure is usually associated with conditions like high blood pressure and coronary artery disease. But as many as half of heart failure patients could have low levels of the thyroid hormone T3 in their heart tissue. Studies have suggested that low levels of cardiac T3 could be influencing heart dysfunction and symptoms of cardiac disease. Scientists have now found that a common blood test could be used in a new way, as a biomarker to predict when low T3 levels are causing heart trouble. The findings, which have been reported in Frontiers in Physiology, may aid in the creation of new treatments for heart failure that may save lives.

Image credit: Public domain pictures

When a person's heart is unable to keep up with the body's needs, they may become short of breath, get a rapid heartbeat, or swollen legs. In recent years, research studies have suggested that low levels of thyroid hormone could be raising the risk of death in patients with heart failure, and that if cardiac thyroid levels are restored to normal, heart function improves significantly. Low cardiac T3 symptoms are also very similar to other disorders that can cause heart failure. Still, doctors are reluctant to prescribe the hormone to heart patients because of the risk of side effects like irregular heartbeat, and little is known about dosage.

"I have been rather obsessed with the need for a serum biomarker for cardiac tissue T3 levels for many years," said the Frontiers study author Martin Gerdes, Ph.D., chair and professor of biomedical sciences at New York Institute of Technology College of Osteopathic Medicine (NYITCOM).

The heart releases a molecule called brain natriuretic peptide (BNP) into the blood when heart failure is happening.  "It dawned on me that the clinical literature showed a very consistent inverse relationship between serum T3 and BNP levels," said Gerdes.

In this study, the researchers used a rat model of heart failure to assess BNP levels, heart function, gene expression, and T3 treatment. They showed that a blood test could indicate whether cardiac T3 levels should be altered to improve heart function.

Thyroid hormones and BNP levels are routinely checked in heart patients, making these levels easy to monitor as part of an existing regimen.

"The results were remarkable, suggesting that serum BNP levels can be used to titrate the volume of T3 required," revealed Gerdes. "When T3 treatment led to a reduction in serum BNP levels, this was associated with improved cardiac function and reversal of these heart failure genes. The beauty of this biomarker is that it is already in widespread use, so efficacy could be shown quickly."

Sources: AAAS/Eurekalert! via New York Institute of Technology, Frontiers in Physiology

 

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 13, 2020
Cardiology
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
OCT 13, 2020
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
Biomarkers have taken the diagnostic field by storm over the past decade. The search for stable, easy to access indicato ...
OCT 18, 2020
Cardiology
Many Heart Disease Deaths Are Preventable With Diet Improvements
OCT 18, 2020
Many Heart Disease Deaths Are Preventable With Diet Improvements
New research has suggested that over two-thirds of heart disease cases around the world are preventable with improvement ...
NOV 05, 2020
Cardiology
Investigating Platelet-Derived Extracellular Vesicles in Blood Clotting
NOV 05, 2020
Investigating Platelet-Derived Extracellular Vesicles in Blood Clotting
In our bodies, there are millions of signals and packages being sent and received every second. In the past several deca ...
NOV 19, 2020
Cardiology
Examining a Possible Link Between Atherosclerosis and Inflammation
NOV 19, 2020
Examining a Possible Link Between Atherosclerosis and Inflammation
The immune system’s primary duty is to protect the body from dangerous invaders. Many don’t know that it als ...
JAN 26, 2021
Genetics & Genomics
Why Only Some People With a Rare Mutation Get a Heart Condition
JAN 26, 2021
Why Only Some People With a Rare Mutation Get a Heart Condition
Scientists have found a way to explain why a heart condition called hypertrophic cardiomyopathy (HCM) can be so differen ...
MAR 12, 2021
Cardiology
Newly-IDed Atherosclerosis Protein May Be Treatment Target
MAR 12, 2021
Newly-IDed Atherosclerosis Protein May Be Treatment Target
Arteries, which supply the body with oxygen, are normally flexible. But they can become stiff and thick in a condition c ...
Loading Comments...